Drug Discovery Summit  is bringing together 80+ senior leaders across GPCR-focused biopharma from April empowers scientists to simplify complex workflows, accelerate discovery, and drive breakthroughs in drug Whether you're decoding signaling pathways or designing the next generation of therapeutics, Revvity biosensors and BacMam gene delivery tools to measure the spatial and temporal signaling properties of drug delivers kinetic profiles that reliably inform decisions and reduce the risk and cost of developing new drugs

Is Your GPCR Program Slowing Down—Even With Good Data? You’re not alone. Meetings drag. Decisions stall. And momentum quietly dies. GPCR Ecosystem. Strong science. Promising data. But no systems to turn it into momentum. Here’s what I bring: Biology-First Strategy I’ve designed GPCR assays, led collaborations across research GPCR, I’m connected to 1,300+ scientists and decision-makers worldwide.

That is the entire idea behind the GPCR Happy Hour. It is scientist-only by design, and it is free to every scientist who comes. Axxam Axxam works with drug discovery teams from the very first question, what to go after, all the way Whether you're piecing together a signaling pathway or designing what comes next, Revvity is the kind Who should come If you work on GPCRs, this is for you.

Innovative Approaches in GPCR Drug Discovery: Designing Precise Solutions for GPCR Challenges. That’s exactly what Terry’s Corner delivers this week: a deep dive into molecular creativity, rational design , nature’s molecules still outperform many designed compounds. • The Power of Structure : How privileged : GPCR-focused chemical design is evolving—fast. Whether you’re designing the next assay, scouting a new therapeutic angle, or exploring career pivots

Masterclass on GPCR Allostery: Unveiling Techniques to Decode Drug Behavior – July 31st, 2025. Welcome back GPCR fans, If your drug discovery strategy still relies on static GPCR models, you’re already Some drugs take hours to reach equilibrium—not because of poor design, but because the system is fluid Why you need to be there: Learn how kinetic nuance shapes ligand design.   lectures, classified industry news, priority event alerts, job opportunities, and insider commentary—designed

GPCR. of GPCR research and drug discovery. Terry's Corner - Unlock the Power of Target Residence Time in Your GPCR Drug Discovery Pipeline Gain Designed for GPCR scientists and translational teams, Premium keeps you informed on the science, careers , and business moves shaping drug discovery.

Whether you’re early in your career or pushing the edge of MoA design, weekly lesson help you apply key Terry Kenakin   Terry’s Corner is your space focused on GPCR pharmacology designed just for you.   With strong signal stability, HTS compatibility, and broad assay versatility, CELT-419 is designed for oncogenic signaling in lymphoid neoplasms, and its disruption boosts sensitivity to the apoptosis-inducing drug GPCR Team

Watch Episode 175 From failed assays to breakthroughs in GPCR modeling , Dr. When he returned to Sweden for his PhD, he focused on small molecule design. behavior post hoc, his group began developing workflows and strategies that could drive experimental design predictions—a sentiment that highlights the skepticism that still exists around modeling in some corners of drug For early-career researchers, the takeaway is direct: GPCR drug discovery will increasingly depend on

Target-based screening is now a fundamental pillar of drug development, and GPCRs are key targets for This makes them very useful for GPCR drug discovery, since receptors are a lot bigger than their small Optimizing GPCR Drug Discovery with Fluorescence Polarization: Key Advantages and Future Perspectives Compatible with various sources of GPCRs. Contact us  to drive further advancements in GPCR drug discovery!  

Unlocking the Puzzle: The Importance of Precision in GPCR Programs and the Hidden Costs of Overlooking Hiring Won’t Save Your GPCR Drug Discovery Program When a drug discovery program stalls, the default Bad Data Management Is Undermining Your GPCR Drug Discovery Team The real problem isn’t competence. Without a unified drug discovery data management  pipeline, teams waste hours cleaning, reconciling, Build Precision Systems for GPCR Drug Discovery The only way out for GPCR drug discovery programs isn

drug discovery. The competitive assay design and optimization were performed in the University of Western Australia. The competitive assay design and optimization were performed in the University of Western Australia. For research teams, this provides a practical framework for integrating fluorescent ligand design with Design, Radiosynthesis, and Biodistribution of a New Potent and Selective Ligand for in Vivo Imaging

Enhancing scientific exploration by concentrating on understanding inhibition to advance GPCR drug discovery This Week’s GPCR Intelligence: Every drug you design will meet an enzyme before it meets its receptor Whether you’re designing a ligand, optimizing ADME, or predicting PK, enzyme inhibition defines what When “inhibition” becomes activation—and how that insight fuels next-gen therapeutic design. field 🧠 Designed for researchers at every career stage

For drug hunters working at the GPCR interface, the difference between a successful lead and a dead-end For GPCR drug discovery, those hidden details can determine whether a compound advances or stalls.  can uncover hidden efficacy, silent antagonism, or even inverse agonism. ✅ Practical insights into designing The Hidden Lever in GPCR Research In GPCR pharmacology, the conversation often centers on ligand properties—affinity In an era of accelerated GPCR-targeting innovation, these advantages define which programs advance and

Every September, Boston welcomes the global biotech and drug discovery community. drug discovery. Their expertise, collaboration, and commitment to quality make them an indispensable partner in modern drug Axxam Axxam is a leading provider of integrated discovery services, supporting the entire drug discovery important and validated target classes in drug discovery.

Rational Drug Design One immediate application of this research lies in rational drug design . This distinction is essential for designing drugs that selectively target these residues to achieve desired For example, orthosteric drug design —in which drugs bind to the receptor’s primary active site—can now Evolutionary Insights and Drug Design From an evolutionary standpoint, the study reveals that residues Conclusion In summary, the findings of this study have significant implications for drug design, personalised

It is a quietly common story wherever people rely on GPCR antibodies, and it is where our conversation We tend to say a GPCR antibody is “validated,” as if validation were a box that could be checked and For a class of reagents as demanding as GPCR antibodies, that humility turns out to be the point. Why GPCR antibodies punish you early Good GPCR antibodies are notoriously hard to make, and the reasons behaves the same way years from now, without the batch-to-batch drift that has quietly undermined so much drug

Watch Episode 175 If your model can’t predict the future of GPCR drug discovery, why build it at all? insights not just to explain receptor–ligand interactions after the fact, but to forecast outcomes and design When existing compounds are exhausted, bespoke ligands are designed and synthesized in-house. Can we design compounds that trigger biased signaling? But part of their rigor lies in restraint. GPCR Premium Ecosystem  for advanced insights into structure-based modeling, ligand design, and experimental

Upcoming events:  Adhesion GPCR Workshop; GRC—Transporters, Ion Channels & GPCRs; MPGPCR Joint Satellite Terry’s Corner: GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures Discovery collapses GPCR Podcast: Chemical Probes for GPCR Imaging with Dr. Johannes Broichhagen explains how next-generation fluorescent probes—designed with precise synthetic His work shows why chemical design can outperform antibodies and how rigorous assay validation bridges

Welcome GPCR Fans,   In GPCR-targeted drug discovery, precision isn’t optional—it’s a requirement. GPCR Premium Members this week gain curated, early access to: Industry insights : GPCRs and mRNA in drug Ingo Hartung : State-of-the-art design of small molecule drugs, including PROTACs Dr. His leadership principles: Hire for attitude and team fit—not just credentials Design workflows that GPCR Premium is designed for scientists who need the right intelligence, fast—without noise, distractions

the therapeutic contexts where single-receptor pharmacology is a precision mismatch Hybrid ligand design It is incomplete in a way the assay cannot disclose by design. Steady-state assays answer the question they are designed to answer: what is the net effect at equilibrium They are not designed to disaggregate that net effect into its components. framework: why certain disease architectures require multi-target engagement in the first place, the design

Elevate Your GPCR Science with Essential Frameworks for Precision Drug Discovery: An Insight into Advanced , Not Breakdowns In the fast-paced world of GPCR drug discovery, the "go fast" mindset can often lead GPCR-Based Drug Discovery conference is where the future of GPCR therapies will be defined. lessons, classified industry news, priority event alerts, job opportunities, and insider commentary—all designed GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who

Purinergic GPCR Ligand Design: A3AR and P2Y14 in Neuropathic Pain A3AR and P2Y14 represent mechanistically with Kenneth Jacobson and Matteo Pavan examines the structural determinants that make selective ligand design allosteric sites at A3AR operate independently of the orthosteric pocket, with implications for PAM design Signaling and Translation Tired of HEK293 cells as a model for drug discovery? It's a comprehensive reference on GPCR drug discovery project initiation, target selection, ligand characterization

The GPCR Happy Hour Room What struck me first was the range. GPCR Happy Hour is free to every scientist who walks in. GPCR YouTube channel, and I encourage you to watch it. GPCR: welcome. This is what we do. Come find us in the fall. the people https://www.ecosystem.drgpcr.com/gpcr-university

Months were spent debating assay design. IP1 isn’t naturally abundant or easy to detect. Eventually, the team landed on a design that could accumulate and detect IP1 in a 384-well format. David Parker spent years designing rare-earth europium probes. Trinquet’s team designed pHSense to detect that, without microscopy. It’s a strategic tool for decoding GPCR behavior in drug discovery and systems biology.

But the moment I designed my own experiment, I was hooked. By 2011, she had established her own group within the Drug Discovery Biology theme at Monash Institute Why GPCR Spatial Signaling Is Changing Drug Discovery Today, Michelle leads the Spatial Organization drug discovery and precision targeting. It’s a new language for drug discovery.

GPCR Allosteric Modulators as Novel Intracellular Molecular Glues Classic models explain biased signaling Reserve your spot ➤ iPSC-Derived Systems for GPCR Signaling and Translation Heterologous systems such From the Masterclass Library Premium Members also have access to Decoding Drug Action with Dr. GPCR Dr. GPCR brings together scientists working across GPCR biology, pharmacology, and drug discovery to examine

Snapshot of roles spanning PhD entry points to senior translational pharmacology—Protein Expression, Drug how construct design and solubilization choices shape success. GPCR innovation is accelerating. Aside from his vast experience in drug development, not to mention his extensive publication record, field 🧠 Designed for researchers at every career stage Don’t just keep up — lead the way 🚀 Join Premium

allostery and biased signaling are redefining drug design The Long Arc of Chemical Pharmacology The early history of drug discovery was rooted in nature . Allostery and Biased Signaling Change the Game The most profound change in GPCR drug discovery is our GPCRs are not simple on/off switches. GPCR innovation is accelerating.

If your team is designing covalent or tight-binding candidates, these principles reduce surprises and Designing for penetration —balance on/off rates to reach inner tissue, not just peripheries. Watch our new trailers for a preview of expert-led GPCR training designed for scientists and drug hunters Kenakin… sorely needed in the field." — DrGPCR University Attendee 🚀 Join now — and learn to design field 🧠 Designed for researchers at every career stage

how kinetics shape drug action, and how all of it translates into programs. Sam Hoare  — How Signaling Kinetics Shapes GPCR Drug Action. May 14. Andrew Tobin  — How to Build Breakthrough GPCR Programs. June 4. GPCR community gathers in person next week. GPCRs Targeted Drug Discovery Summit  — April 28–30. GPCR Dr. GPCR is the intelligence and community for GPCR scientists.